Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-Acetyl-cysteine protects against cardiac damage from subsequently-administered cardio-toxic anthra-cycline in cancer therapy

N-Acetyl-cysteine protects against cardiac damage from subsequently-administered cardio-toxic anthra-cycline in cancer therapy

US Patent 4331648 · Granted May 25, 1982

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases2020
Iodonium analogs as inhibitors of NADPH oxidases and other flavin dehydrogenases2018
Antibodies that specifically bind ataxia telangiectasia-mutated and RAD3-related2017
Mice with combined disruption of Gpx1 and Gpx2 genes have growth retardation, hy2004
Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modali2000
Protector for wrist watch lens or the like2000
Protector for wrist watch lens1999
Steroid secreting human adrenocortical carcinoma cell lines1998
Use of purinergic receptor agonists as antineoplastic agents1997
Monoterpenes, sesquiterpenes and diterpenes as cancer therapy1997
Use of purinergic receptor agonists as antineoplastic agents1995
Suramin and active analogues thereof in the treatment of hypercalcemia1992